In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...
Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.
News-Medical.Net on MSN6d
Yale research supports MRD detection for post-treatment lung cancer careIn the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...
Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...
A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.
A new Yale study has found evidence to support the value of a tool that measures the presence of cancer -derived molecules in ...
Conversely, MRD could also identify patients with low risk of recurrence, possibly sparing them from further treatment and any associated drug toxicities as a result.
In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of ...
Treatment Blood Test Offers New Hope for Personalized Cancer Therapy DecisionsA new Yale study has found evidence to support ...
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback